Talking Medicines develops patient insight tool
The tool collects data from social media, forums and blogs, mapped to a database of 130,000 global medicines.
It includes patient confidence scores for medicines to offer benchmarks for pharmaceutical marketers.
Jo Halliday, chief executive, Talking Medicines, said: “By using cutting edge artificial intelligence, machine learning and natural language processing models, we’re able provide real time social intelligence in a straightforward, intuitive way.”
Formed in 2013, Talking Medicines is headquartered in Glasgow and raised £1.1m in funding in November 2020.
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments